Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational studyMaartje E. Meier, Natasha M. Appelman‐Dijkstra, Stance N. Clerkx et al.|Journal of Bone and Mineral Research|2020Cited by 49
A multidisciplinary care pathway improves quality of life and reduces pain in patients with fibrous dysplasia/McCune-Albright syndrome: a multicenter prospective observational studyMaartje E. Meier, Natasha M. Appelman‐Dijkstra, Sarina E. C. Pichardo et al.|Orphanet Journal of Rare Diseases|2022Cited by 12
The Natural Course of Pain in Fibrous Dysplasia/McCune Albright Syndrome: A Prospective Follow Up StudyOana O Bulaicon, Natasha M. Appelman‐Dijkstra, Marlous Hagelstein-Rotman et al.|Calcified Tissue International|2025Cited by 1
Author response for "Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study"Maartje E. Meier, Natasha M. Appelman‐Dijkstra, Elizabeth M. Winter et al.|Unknown|2021Cited by 0
A multidisciplinary care pathway improves quality of life and pain in patients with fibrous dysplasia/McCune-Albright syndrome: a multicenter prospective observational studyMaartje E. Meier, Natasha M. Appelman‐Dijkstra, Marlous Hagelstein-Rotman et al.|Research Square|2022Cited by 0